Our team had an amazing time at the #ALSNexus conference hosted by The ALS Association. 💙 Here's what Eric Anderson MD PhD MBA FAAN, Synapticures VP of Clinical Operations, had to share about his experience: "The ALS Nexus conference was one of collaboration and progress, bringing together leaders in the field to drive meaningful advancements. The Association went above and beyond to ensure it was accessible and welcoming to PALS and their caregivers. What truly set this event apart was the active participation of renowned clinicians, leading researchers, and PALS themselves. It was a unique and inspiring experience of inclusion and innovation." #ALS #Inclusion #Innovation #Collaboration
Synapticure Inc.
Hospitals and Health Care
Chicago, IL 3,498 followers
The era of personalized care is finally coming to Neurodegenerative disease
About us
Synapticure brings expert virtual care to individuals and caregivers living with neurodegenerative diseases, including Parkinson's, Alzheimer's and related dementia, ALS, and more conditions. Our mission is to democratize access to cutting-edge and personalized care provided by neurologists, mental health providers, and care navigators here for you 24/7.
- Website
-
https://synapticure.com
External link for Synapticure Inc.
- Industry
- Hospitals and Health Care
- Company size
- 11-50 employees
- Headquarters
- Chicago, IL
- Type
- Privately Held
- Founded
- 2019
- Specialties
- GUIDE, Lewy Body, Motor Neuron, Diagnosis, and Medication support
Products
Synapticure Care
Patient Engagement Software
Synapticure is the neurodegenerative disease easy button for patients and clinicians. We provide care the way patients and their caregivers need it, providing a full multidisciplinary clinic for patients on their time and from the comfort of their home. We prioritize access, experienced and heartfelt staff who's lived the journey of diseases like ALS, Parkinson's, Alzheimer's and more, and covered by insurance. We provide virtual and in-home multidisciplinary care for patients living with Dementia, Motor neuron and Movement disorders in all 50 States, built around the patient and their caregiver instead of the four walls of the clinic. This includes: - Care Coordination for patients and their caregiver - Expert specialist neurologist available in days, not months - Insurance navigation & DME support - Home Health, PT, OT, RT - Medication and prior-auth - Local non-profit support - A resource you can get in touch with for help 24/7
Locations
-
Primary
Chicago, IL 60613, US
Employees at Synapticure Inc.
Updates
-
We’re proud to have clinicians like Dr. Tracey Meyers on our team. Dr. Meyers exemplifies our commitment to personalized mental health care, bringing her expertise and compassion to every patient interaction. Discover how her tailored approach is making a significant impact on the lives of patients and their loved ones. To learn more visit synapticure.com or give us a call at (855) 255-5917.
-
Synapticure's lab directors, Martina de Majo and Layla Starr, wrapped up an incredible week at #ISSCR24 in Hamburg. Dr. Starr shared, "We were so inspired by the breakthroughs occurring in stem cell research and the innovative therapies on the horizon. We were also thrilled to share our 3D mature brain organoid model for neurodegeneration with the brightest minds in this field." If you want to learn more about our research and development, don't hesitate to reach out!
-
-
Our team was honored to join the commemoration of the 10th year of the #IceBucketChallenge at #ALSNexus. Being part of this event reaffirms our commitment to supporting the ALS community and advancing care for those affected by neurodegenerative diseases. 💙 If you're attending the conference, don't forget to stop by Booth #04 and say hi to our team! 👋 We’d love to connect and share how we’re dedicated to delivering cutting-edge care for those living with ALS and other neurodegenerative conditions. The ALS Association
-
-
If you're attending #ALSNexus, don't forget to stop by and say hi to our team at Booth #04! We'd love to connect with you and talk more about our mission to provide state-of-the-art care for everyone living with ALS and other neurodegenerative diseases. Whether you're attending in person or virtually, don't miss our very own Dr. Eric Anderson MD PhD MBA FAAN discussing how multidisciplinary clinics can best care for people with #ALS and how we are breaking down barriers to improve access. Today during Breakout Session 2 at 11:30 am!
-
-
A huge thank you to Dr. Padma R. Mahant, MD for sharing with our team and community about the critical need for accurate diagnostic testing, especially for complex conditions like #Parkinsons and other #neurodegenerative diseases. With 95% accuracy, the Syn-One Test® from CND Life Sciences is transforming early intervention. Discover advances in diagnostic tools for neurological diseases by clicking here: https://lnkd.in/dcW7rEfQ
Padma R. Mahant, MD, Director of Medical Affairs at CND Life Sciences, recently participated in a discussion about the Syn-One Test® with Drs. Liz Ferluga and Jaime Hatcher-Martin of Synapticure Inc., a teleneurology and patient support clinic based in Chicago. Dr. Mahant outlines the science behind the Syn-One Test, the results of the recently published Synuclein-One Study, and the various benefits the test has offered to her patients. “I think we’re looking at a new diagnostic paradigm,” says Dr. Mahant. Find out more https://lnkd.in/dSWi44TE Rick Morello Todd Levine #parkinsons #parkinsonsdisease #alphasynuclein #dementiawithlewybodies #synonetest
-
-
Synapticure is proud to be part of the #ALSNexusConference, The ALS Association, from July 14-17. We're honored to have Eric Anderson MD PhD MBA FAAN in attendance to discuss the critical role of multidisciplinary clinics in providing top-tier care for people living with ALS and strategies to overcome barriers to access, like fostering partnerships to ensure equitable access to care. Visit us at Booth #4 to connect with our team and discover more about how Synapticure is working to transform care for those living with neurodegenerative diseases. Together, we can create a future where state-of-the-art care is accessible to everyone.
-
-
We are dedicated to providing comprehensive support for individuals living with #Parkinson’s disease. Our integrated approach ensures that every aspect of patient care is proactively addressed and managed. Here’s how: 🧠 Fast access to movement disorder specialists 🧬 Personalized care plans tailored to patients and caregivers' needs 💙 Mental health support from neuropsychologists 💊 Medication and symptom management 💪 Wrap-around services: speech or physical therapy and more We're here to provide patients and caregivers with the highest standard of care and support. For more information, contact us at (855) 255-5917 or visit synapticure.com.
-
"Also, being remote allows us, her daughters, to easily participate even though we live in different states, plus it allows my mom to have her appointments without ever leaving the house." Hearing how our virtual care platform helps families stay connected and patients feel valued is why we do what we do. We're committed to providing expert, compassionate care that meets your needs, wherever you are. Thank you for trusting us with your care. 💙
-
We are thrilled to announce that the National Plan to End Parkinson’s Act has been officially signed into law! Here’s why this law is a game-changer: ✅ Increased Federal Research Funding: A significant boost to advance research for better treatments and a potential cure. ✅ Improved Early Diagnosis & Effective Treatments: New pathways to enhance early diagnosis and develop more effective treatment options. ✅ New Standards for Prevention & Care: Establishes guidelines for preventing Parkinson’s and advancing patient care models. ✅ Addressing Health Disparities: A focus on ensuring equitable access to diagnosis, treatment, and clinical trials for all individuals affected by Parkinson’s. We are proud to be part of a community that is making strides toward ending Parkinson’s and improving the lives of those affected by this disease and we are excited about what this means for the future of Parkinson’s care and research.
🚨 Breaking News: President Biden has signed the National Plan to End Parkinson’s Act into law! This is the first-ever federal legislation dedicated to ending Parkinson’s disease. This monumental bill can make an impact by: 💵 Dramatically increasing federal research funding 🔬 Developing more effective pathways for treatments and cures 🩺 Improving early diagnosis 🥼 Sparking new and improved models for patient care ⚖️ Addressing health disparities in diagnosis, treatment, and clinical trial participation We would like to thank all the Parkinson’s advocates, volunteers and people who wrote to their senators and representatives to make this bill become law. “The Parkinson’s Foundation is excited for what comes next,” said John Lehr, Parkinson’s Foundation President and CEO. “We look forward to having input in designing exactly how this bill will mobilize meaningful change for the one million Americans living with this disease.” Learn more: https://lnkd.in/gNU9tYc8
-